Please login to the form below

Not currently logged in
Email:
Password:

Pfizer/BioNTech

This page shows the latest Pfizer/BioNTech news and features for those working in and with pharma, biotech and healthcare.

Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents

Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents

In the UK, the Pfizer/BioNTech is currently only approved for use to prevent COVID-19 in individuals aged 16 and over. ... In March, Pfizer and BioNTech revealed positive data for their vaccine in adolescents aged 12 to 15, both with or without prior

Latest news

More from news
Approximately 52 fully matching, plus 105 partially matching documents found.

Latest Intelligence

  • Rare genetic diseases – what’s in store for 2021? Rare genetic diseases – what’s in store for 2021?

    In the UK, the looming Brexit sparked new models of regulatory approval and fast-track opportunities, as recently observed in the rapid approval of Pfizer’s COVID-19 vaccine. ... So far the Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University

  • Working together against COVID-19 Working together against COVID-19

    Beyond the connection between HCPs and pharma or NGOs, it is encouraging to see collaborations such as Clover and GSK evaluating a vaccine candidate and Pfizer and Biontech doing the same. ... A number of top pharma companies are included in the newly

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • What does the COVID-19 vaccine mean for the future of R&D?

    Both the Oxford/AstraZeneca and Pfizer/BioNTech vaccines were developed using platform technologies which didn’t exist 20 years ago, allowing these vaccines to be developed much faster.

  • The UK has approved the first vaccine for COVID-19. What now?

    The authorisation of Pfizer/BioNtech's mRNA vaccine by the MHRA is great news, but no-one has ever tried to roll out a vaccine as rapidly as this one, so

  • Mistrust in medical research: a patient perspective

    Health Products Regulatory Agency’s speedy  approval of the Pfizer-BioNTech COVID-19 vaccine in the UK. ... A good example is a recent incident in the UK that made headline news, where two NHS workers who were among the first to receive the

  • Is the world ready for a COVID-19 vaccine?

    At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more than 90% effective at preventing COVID-19 infection. ... At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more

  • Hanover Communications Hanover Communications

    At the beginning of November, Pfizer and BioNTech announced that their vaccine candidate was more than 90% effective at preventing COVID-19 infection.

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....